Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|June 1, 1991
Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in ratsY Iino, N Sugamata, S Owada, et al.
Nihon Gan Chiryo Gakkai Shi|October 20, 1989
[Mass screening for breast cancer in Gunma prefecture--the results for 8 years and future problems]T Ishida, T Yokoe, T Ogawa, et al.
Oncology|January 1, 1992
Intersite variation of estrogen receptors in human breast cancers and response to endocrine therapy. Which section of a large tumor is the best for estrogen receptor assay?Y Iino, N Sugamata, M Maemura, et al.
Anticancer Research|September 1, 1995
Phase II trial of mitoxantrone, doxifluridine and medroxyprogesterone acetate as second-line treatment for anthracycline-resistant metastatic breast cancerT Yokoe, Y Iino, N Sugamata, et al.
International Journal of Molecular Medicine|July 14, 1999
The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancerY Koibuchi, N Sugamata, Y Iino, et al.
Oncology Reports|April 16, 1999
Effects of interferon-alpha on cellular proliferation and adhesion of breast carcinoma cellsM Maemura, Y Iino, J Horiguchi, et al.
Surgery Today|January 1, 1995
Screening for abdominal aortic aneurysm and occlusive peripheral vascular disease in Japanese residentsH Takei, S Ishikawa, A Otaki, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in JapanT Ishida, T Yokoe, F Kasumi, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1992
The effect of breast self-examination on early detection and survivalT Kuroishi, S Tominaga, J Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1994
[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)]J Kobayashi, K Kubota, H Ishikawa, et al.
Pageof 11